|
HPRT1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.341700E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.134000E-02 |
| Normal-vs-Stage2 |
1.699650E-01 |
| Normal-vs-Stage3 |
2.540200E-01 |
| Normal-vs-Stage4 |
8.796600E-01 |
| Stage1-vs-Stage2 |
9.990200E-01 |
| Stage1-vs-Stage3 |
5.514000E-01 |
| Stage1-vs-Stage4 |
1.744250E-01 |
| Stage2-vs-Stage3 |
6.938800E-01 |
| Stage2-vs-Stage4 |
2.728800E-01 |
| Stage3-vs-Stage4 |
4.342400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.321550E-01 |
| Normal-vs-AfricanAmerican |
2.388800E-01 |
| Normal-vs-Asian |
9.447600E-01 |
| Caucasian-vs-AfricanAmerican |
4.782000E-01 |
| Caucasian-vs-Asian |
3.285400E-01 |
| AfricanAmerican-vs-Asian |
2.809000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.389400E-01 |
| Normal-vs-Female |
1.687800E-02 |
| Male-vs-Female |
3.684100E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.457700E-02 |
| Normal-vs-Age(41-60Yrs) |
3.993200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.259360E-01 |
| Normal-vs-Age(81-100Yrs) |
3.294800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.058840E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.257400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.984800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.377600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.932600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.813600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.861840E-01 |
| Classical-VS-Follicular |
3.159600E-01 |
| Classical-VS-Other |
2.967800E-01 |
| Classical-VS-Normal |
1.120040E-01 |
| Tall-VS-Follicular |
6.593600E-01 |
| Tall-VS-Other |
1.537830E-01 |
| Tall-VS-Normal |
4.032400E-02 |
| Follicular-VS-Other |
2.548400E-01 |
| Follicular-VS-Normal |
4.765500E-02 |
| Other-VS-Normal |
7.011600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.640220E-01 |
| Normal-vs-N1 |
7.679400E-01 |
| N0-vs-N1 |
4.643400E-01 |
|
|
